Valuation: Orthofix International NV

Market Cap 38Cr 33Cr 30Cr 28Cr 54Cr 3.6TCr 55Cr 365.13Cr 141.51Cr 1.76TCr 141.91Cr 138.83Cr 6.08TCr P/E 2026 *
-7.7x
P/E 2027 * -9.26x
Enterprise Value 38Cr 33Cr 30Cr 28Cr 54Cr 3.6TCr 55Cr 365.13Cr 141.51Cr 1.76TCr 141.91Cr 138.83Cr 6.08TCr EV / Sales 2026 *
0.45x
EV / Sales 2027 * 0.43x
Free-Float
97.81%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 54 08/01/2024
Director of Finance/CFO 55 15/01/2024
Compliance Officer - 01/02/2015
Director TitleAgeSince
Director/Board Member 66 16/03/2016
Director/Board Member 54 08/06/2020
Director/Board Member 64 05/01/2023
Change 5-day change 1-year change 3-year change Capi.($)
+1.33%+0.91% - - 38Cr
+3.15%+2.58%-28.68%-10.79% 16TCr
+4.05%+2.52%-6.49%-5.27% 10TCr
+1.71%+1.86%+0.38%+53.10% 5.61TCr
-1.22%-2.88%+53.69%+49.87% 5.34TCr
+2.36%+3.67%-11.47%-40.08% 4.21TCr
+2.37%+13.34% - - 3.53TCr
+3.35%+3.80%-14.74%-43.90% 2.66TCr
+0.09%+5.57%+65.38%-3.30% 2.58TCr
+2.20%+3.28%-8.71%-0.74% 2.07TCr
Average +1.94%+3.11%+6.17%-0.14% 5.8TCr
Weighted average by Cap. +2.43%+2.01%-3.59%+0.86%

Financials

2026 *2027 *
Net sales 84Cr 74Cr 68Cr 63Cr 119.35Cr 8.01TCr 121.36Cr 812.79Cr 315Cr 3.93TCr 315.9Cr 309.03Cr 14TCr 88Cr 77Cr 71Cr 66Cr 125.04Cr 8.39TCr 127.15Cr 851.6Cr 330.03Cr 4.12TCr 330.98Cr 323.78Cr 14TCr
Net income -4.75Cr -4.15Cr -3.81Cr -3.55Cr -6.74Cr -452.09Cr -6.85Cr -46Cr -18Cr -221.75Cr -18Cr -17Cr -764.08Cr -4.04Cr -3.53Cr -3.24Cr -3.02Cr -5.73Cr -384.41Cr -5.82Cr -39Cr -15Cr -188.55Cr -15Cr -15Cr -649.69Cr
Net Debt - -
Logo Orthofix International NV
Orthofix Medical Inc. is a global medical technology company. It offers a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH Navigation System. Its Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. It provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market that encompasses four pillars: deformity correction, limb lengthening, complex fracture management, and limb preservation.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-